CVR: 41277688
MLMC Therapeutics ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Michael Henrik Stadi. The company's owners include Ritika Singh Petersen, Sriram Thoppe Rajendran and FOMT HOLDING ApS. In 2025, the company reported a gross profit of DKK -30,768 and a net result of DKK -144,214 compared with DKK -134,525 the year before. Equity amounted to DKK -483,287.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er forskning i og udvikling af teknologi til produktion af oral medicin, samt aktiviteter, som efter ledelsens skøn naturligt står i forbindelse hermed.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorScreen owners and management against the Danish FSA's official PEP lists
MLMC Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -30,768, and the net result was DKK -144,214.
MLMC Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -26,638, and the net result was DKK -134,525.
MLMC Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -25,639, and the net result was DKK -122,678.
MLMC Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -29,822, and the net result was DKK -90,240.
As of May 1, 2023, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of MLMC Therapeutics ApS.
As of June 15, 2022, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of MLMC Therapeutics ApS.
As of June 15, 2022, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of MLMC Therapeutics ApS.
MLMC Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK -19,909, and the net result was DKK -53,670.
As of September 30, 2021, Ritika Singh Petersen is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
As of September 30, 2021, Sriram Thoppe Rajendran is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
MLMC Therapeutics ApS has published its interim report for the period April 3, 2020 – December 31, 2020.
As of April 27, 2020, FOMT HOLDING ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 10%.
As of April 27, 2020, CORIDATS CAPITAL ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 10%.
As of April 27, 2020, Scantox Ballerup ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
As of April 27, 2020, FOM TECHNOLOGIES A/S is registered as an owner of MLMC Therapeutics ApS with an ownership share of 50%.
As of April 27, 2020, HDJ & LEJ Invest ApS is registered as an owner of MLMC Therapeutics ApS with an ownership share of 5%.
As of April 3, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MLMC Therapeutics ApS.
As of April 3, 2020, Hanne Damgaard Jensen has joined the board of directors of MLMC Therapeutics ApS.
As of April 3, 2020, Peter Gudmund Nielsen has joined the board of directors of MLMC Therapeutics ApS.
As of April 3, 2020, Martin Kiener has joined the board of directors of MLMC Therapeutics ApS.
As of April 3, 2020, Michael Henrik Stadi is registered as adm. dir. of MLMC Therapeutics ApS.
MLMC Therapeutics ApS was founded on April 3, 2020.
Companies in the same industry and area
CVR 34715726
CVR 37723312
CVR 16313440
CVR 38789902
CVR 31208874
companydata.dk